120 related articles for article (PubMed ID: 38000525)
21. Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.
Immanuel CN; Teng B; Dong BE; Gordon EM; Luellen C; Lopez B; Harding J; Cormier SA; Fitzpatrick EA; Schwingshackl A; Waters CM
Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L367-L376. PubMed ID: 38252657
[TBL] [Abstract][Full Text] [Related]
22. Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.
Li T; Fu B; Zhang X; Zhou Y; Yang M; Cao M; Chen Y; Tan Y; Hu R
Cancer Immunol Res; 2021 Sep; 9(9):1008-1023. PubMed ID: 34285037
[TBL] [Abstract][Full Text] [Related]
23. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
Dai Y; Jiao H; Teng G; Wang W; Zhang R; Wang Y; Hebbard L; George J; Qiao L
Mol Cancer Ther; 2014 May; 13(5):1206-16. PubMed ID: 24651526
[TBL] [Abstract][Full Text] [Related]
24. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
25. Luxeptinib disables NLRP3 inflammasome-mediated IL-1β release and pathways required for secretion of inflammatory cytokines IL-6 and TNFα.
Sonowal H; Zhang H; Rice W; Howell SB
Biochem Pharmacol; 2022 Jan; 195():114861. PubMed ID: 34843717
[TBL] [Abstract][Full Text] [Related]
26. Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies.
Leu WJ; Chu JC; Hsu JL; Du CM; Jiang YH; Hsu LC; Huang WJ; Guh JH
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339319
[TBL] [Abstract][Full Text] [Related]
27. VSIG4 mediates transcriptional inhibition of
Huang X; Feng Z; Jiang Y; Li J; Xiang Q; Guo S; Yang C; Fei L; Guo G; Zheng L; Wu Y; Chen Y
Sci Adv; 2019 Jan; 5(1):eaau7426. PubMed ID: 30662948
[TBL] [Abstract][Full Text] [Related]
28. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation
Zhu H; Jian Z; Zhong Y; Ye Y; Zhang Y; Hu X; Pu B; Gu L; Xiong X
Front Immunol; 2021; 12():714943. PubMed ID: 34367186
[TBL] [Abstract][Full Text] [Related]
29. Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer.
Qiao S; Lv C; Tao Y; Miao Y; Zhu Y; Zhang W; Sun D; Yun X; Xia Y; Wei Z; Dai Y
Cancer Lett; 2020 Oct; 491():162-179. PubMed ID: 32861708
[TBL] [Abstract][Full Text] [Related]
30. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
31. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
32. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
He Y; Franchi L; Núñez G
J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
[TBL] [Abstract][Full Text] [Related]
33. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.
Guo W; Sun Y; Liu W; Wu X; Guo L; Cai P; Wu X; Wu X; Shen Y; Shu Y; Gu Y; Xu Q
Autophagy; 2014 Jun; 10(6):972-85. PubMed ID: 24879148
[TBL] [Abstract][Full Text] [Related]
34. NLRP3 inflammasome function and pyroptotic cell death in human placental Hofbauer cells.
Abrahams VM; Tang Z; Mor G; Guller S
J Reprod Immunol; 2020 Nov; 142():103214. PubMed ID: 33152658
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
36. p58(IPK) suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages.
Boriushkin E; Wang JJ; Li J; Bhatta M; Zhang SX
Sci Rep; 2016 Apr; 6():25013. PubMed ID: 27113095
[TBL] [Abstract][Full Text] [Related]
37. hnRNPK knockdown alleviates NLRP3 inflammasome priming by repressing FLIP expression in Raw264.7 macrophages.
Feng J; Li H; Li J; Meng P; Wang L; Liu C; Zhao S; Sun W; Zhang Y
Redox Rep; 2020 Dec; 25(1):104-111. PubMed ID: 33269646
[No Abstract] [Full Text] [Related]
38. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
39. Chicken cathelicidin-2 promotes IL-1β secretion via the NLRP3 inflammasome pathway and serine proteases activity in LPS-primed murine neutrophils.
Peng L; Lu Y; Tian H; Jia K; Tao Q; Li G; Wan C; Ye C; Veldhuizen EJA; Chen H; Fang R
Dev Comp Immunol; 2022 Jun; 131():104377. PubMed ID: 35189160
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages
Wang Y; Wang C; He Q; Chen G; Yu J; Cang J; Zhong M
Front Immunol; 2023; 14():1090202. PubMed ID: 36798132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
